Alnylam Pharmaceuticals Forecast and Stock Analysis
Technical ALNY stock analysis for February 15, 2019.
Alnylam Pharmaceuticals gained 0.60% in the last trading day, rising from $83.03 to $83.53 The price has been going up and down for this period, and there has been a -1.24% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 130 812 more shares were traded than the day before. In total, 528 748 shares bought and sold for approximately $44.17 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the ALNY stock was $83.53. This is 0.6% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 2.12% from a day low at $82.02 to a day high of $83.76.
30 day high of the ALNY stock price was $86.45 and low was $74.29.
90 day high was $90.70 and low was $60.27.
52 week high for the Alnylam Pharmaceuticals - $153.99 and low - $60.27.
Alnylam Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.82% during the next 3 months and, with 90% probability hold a price between $76.69 and $104.29 at the end of this period.
Only positive signals in the chart today. Alnylam Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $82.01 and $80.74. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 64 and the stock is currently not being overbought or oversold
Support & Resistance
Alnylam Pharmaceuticals finds support from accumulated volume at $80.45.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.74 (2.12%) between high and low. For the last week, the stock has had a daily average volatility of 3.41%.
Our recommended stoploss: $78.67 (-5.82%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.